Site icon OncologyTube

Safety Profile of Once-Weekly Regimen Was comparable opposed to the twice-weekly regimen

Martina A. Sersch, MD, Executive Medical Director at Amgen Inc., shares Safety Profile of Once-Weekly Regimen Was comparable opposed to the twice-weekly regimen at Annual Meeting 2018

Exit mobile version